Trial
NCT03052725
A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Collaborators
—
Condition
Eosinophils, Asthma
Intervention
reslizumab
Why stopped
Parent Studies didn't meet their primary endpoint so study was terminated.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-12-14